Welcome to our dedicated page for Nu Skin Enter news (Ticker: NUS), a resource for investors and traders seeking the latest updates and insights on Nu Skin Enter stock.
Nu Skin Enterprises, Inc. (NYSE: NUS) is an integrated beauty and wellness company whose news flow centers on product innovation, device launches, financial performance and global expansion. The company’s public updates highlight its focus on beauty and wellness device systems, nutritional products and anti-aging brands sold through a dynamic affiliate opportunity platform in nearly 50 markets worldwide.
News about Nu Skin often includes announcements of quarterly and full-year financial results, where management discusses revenue, earnings per share, regional performance and non-GAAP metrics such as constant-currency revenue change and adjusted EPS. These releases are frequently accompanied by conference call and webcast details, giving context on operating trends, segment results for the Nu Skin and Rhyz businesses, and guidance ranges.
Another key category of NUS news involves product and technology developments. Recent communications have featured the introduction of Prysm iO, an AI-powered intelligent nutritional wellness platform that measures carotenoid levels through a non-invasive finger scan and connects with Prysm-certified supplements. Nu Skin also issues updates about its portfolio of beauty and wellness device systems and recognition from third parties, such as rankings from Euromonitor International Ltd. for at-home beauty and wellness device systems.
Investors and followers of NUS can also expect news on strategic initiatives, including pre-market and launch activities in emerging markets like India, and commentary on regional trends such as growth in Latin America. Conference participation, moderated fireside chats and strategy discussions at industry events are additional sources of information on the company’s direction. Bookmark this page to monitor Nu Skin’s earnings releases, device and product announcements, geographic expansion updates and other material developments reflected in its news coverage.
Nu Skin Enterprises (NYSE: NUS) will hold an investor day on February 16, 2022, at 10 a.m. MST in Provo, Utah, with options for online participation. The event will feature company leadership, including President and CEO Ryan Napierski, discussing fourth quarter and full-year 2021 results, as well as 2022 financial guidance. Attendees will gain insights into Nu Skin's strategy for personalized beauty and wellness products, its social commerce model, and updates on its digital ecosystem. A replay will be available post-event until March 2, 2022.
Nu Skin's ageLOC LumiSpa has been awarded Product of the Year at the 2021 BIG Awards for Business, recognizing its superior cleansing capabilities that have positively impacted consumers. The device remains a top-seller, cementing Nu Skin's status as a leader in the at-home beauty device market for four consecutive years. This accolade adds to over 30 international awards received by ageLOC LumiSpa, underscoring its effectiveness and innovative design.
Nu Skin Enterprises (NYSE: NUS) announced a milestone of supplying 750 million meals to malnourished children globally through its Nourish the Children initiative since 2002. The initiative delivers VitaMeal, a nutrient-rich food, to kids in over 50 countries, highlighting the company’s commitment to combat childhood hunger. Nu Skin aims to provide one billion meals, reflecting ongoing efforts to address malnutrition.
Nu Skin Enterprises (NYSE: NUS) announced its acquisition of Mavely, a social commerce platform that enhances customer acquisition and social selling. This strategic move aims to empower Nu Skin affiliates to better share and sell products, tapping into the expected $3.4 trillion social commerce market by 2028. The integration of Mavely's technology is anticipated to boost Nu Skin's growth, offering innovative digital tools for a more effective shopping experience. Mavely will operate under Rhyz, Nu Skin's investment arm, continuing its mission in empowering social sellers.
Summary not available.
Nu Skin Enterprises reported Q3 2021 revenue of $641.2 million, a 9% decline year-over-year, with EPS of $0.97, down 10%. The decrease was primarily due to COVID-19 disruptions, particularly in China and Southeast Asia, affecting sales initiatives. Despite challenges, the U.S. market showed growth, notably with the launch of Beauty Focus Collagen+. For Q4, revenue is projected between $645 and $675 million, and EPS is expected at $0.90 to $1.00.
The full-year revenue forecast remains at $2.67 to $2.70 billion, anticipating a 3% to 5% growth.
Nu Skin Enterprises (NYSE: NUS) declared a quarterly cash dividend of $0.38 per share, set to be paid on December 8, 2021. Shareholders on record as of November 26, 2021 will receive this payment. The company focuses on beauty and wellness, leveraging over 35 years of scientific research to develop innovative personal care and nutritional products globally. Nu Skin is committed to sustainability, including reducing packaging waste by 2030. The announcement affirms the company’s ongoing financial health and dedication to rewarding shareholders.
Rhyz Analytical Labs launched analytical testing services for beauty and wellness companies to ensure product safety and effectiveness. Located in Provo, Utah, the lab combines expert scientists with advanced technology to deliver timely, accurate results for foods, dietary supplements, and cosmetics. The company is ISO 17025:2017 accredited and provides a range of testing services including shelf-life testing and microbiological assessments. As part of Nu Skin Enterprises (NYSE: NUS), Rhyz aims to support the entire supply chain for its partners.
Nu Skin Enterprises (NUS) estimates its third-quarter revenue between $637 million and $642 million, lower than expected due to COVID-19 disruptions, particularly in Mainland China and Southeast Asia. CEO Ryan Napierski noted that unanticipated government restrictions impacted sales and promotional activities. Despite these challenges, the launch of Collagen+ in the U.S. contributed to growth, and the company is optimistic about future product launches and social commerce tools. Full third-quarter results will be shared on November 3.
Nu Skin Enterprises reported Q2 2021 revenue of $704.1 million, a 15% increase compared to the prior year, with earnings per share (EPS) of $1.15, up 42%. The growth was attributed to a 260 basis point increase in operating margin, driven by improved profitability and digital commerce advancements. Internationally, sales leaders grew by 15%, while customer numbers saw a 2% decline. Looking ahead, the company projects Q3 revenue between $700-$730 million with EPS of $1.10-$1.20, and is focused on enhancing shareholder value.
FAQ
What is the current stock price of Nu Skin Enter (NUS)?
What is the market cap of Nu Skin Enter (NUS)?
